Bevacizumab for ophthalmic diseases

被引：2
|
作者：
Michels, Stephan [1 ]
Prager, Franz [1 ]
Bakri, Sophie J. [2 ]
Wacht, Joachim [3 ]
机构：
[1] Med Univ Vienna, Gen Hosp Vienna, Dept Ophthalmol, Wahringer Gurtel 18-20, Vienna, Wien 1090, Austria
[2] Dept Ophthalmol, Rochester, MN 55905 USA
[3] Dept Ophthalmol, Berlin, Germany
来源：
EXPERT REVIEW OF OPHTHALMOLOGY | 2007年 / 2卷 / 03期
关键词：
AMD; angiogenesis; anti-VEGF; Avastin ((R)); bevacizumab; choroidal neovascularization; eye; macular degeneration; neovascularization; ocular; vascular endothelial growth factor;
D O I：
10.1586/17469899.2.3.369
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Bevacizumab, a humanized monoclonal antibody that binds to all isoforms of vascular endothelial growth factor, was originally developed to inhibit tumor angiogenesis. Following its approval for the treatment of metastatic colorectal cancer, bevacizumab was initially used systemically in patients with neovascular age-related macular degeneration. Two case reports on intravitreal bevacizumab led to numerous clinical and preclinical studies on bevacizumab. Intravitreal bevacizumab is popular worldwide as an inexpensive off-label treatment for several neovascular ocular diseases. This article reviews the current clinical and preclinical studies using bevacizumab in ophthalmology.
引用
收藏
页码：369 / 378
页数：10
相关论文
共 50 条
  • [31] Bevacizumab in glaucoma: a review
    Ichhpujani, Parul
    Ramasubramanian, Aparna
    Kaushik, Sushmita
    Pandav, Surinder S.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (06): : 812 - 815
  • [32] Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection
    Shimomura, Yukiko
    Hirata, Akira
    Ishikawa, Shinichiro
    Okinami, Satoshi
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (08) : 1089 - 1094
  • [33] Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells
    Merz, Patrick R.
    Roeckel, Nina
    Ballikaya, Seda
    Auffarth, Gerd U.
    Schmack, Ingo
    BMC OPHTHALMOLOGY, 2018, 18
  • [34] Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab
    Park, Sung Chul
    Su, Daniel
    Tello, Celso
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (12) : 1641 - 1647
  • [35] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    Reardon, D. A.
    Herndon, J. E., II
    Peters, K. B.
    Desjardins, A.
    Coan, A.
    Lou, E.
    Sumrall, A. L.
    Turner, S.
    Lipp, E. S.
    Sathornsumetee, S.
    Rich, J. N.
    Sampson, J. H.
    Friedman, A. H.
    Boulton, S. T.
    Bigner, D. D.
    Friedman, H. S.
    Vredenburgh, J. J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1481 - 1487
  • [36] The Eye Is a Window to Systemic and Neuro-Ophthalmic Diseases
    Mortensen, Peter W.
    Wong, Tien Y.
    Milea, Dan
    Lee, Andrew G.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2022, 11 (02): : 91 - 93
  • [37] Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
    D A Reardon
    J E Herndon
    K B Peters
    A Desjardins
    A Coan
    E Lou
    A L Sumrall
    S Turner
    E S Lipp
    S Sathornsumetee
    J N Rich
    J H Sampson
    A H Friedman
    S T Boulton
    D D Bigner
    H S Friedman
    J J Vredenburgh
    British Journal of Cancer, 2012, 107 : 1481 - 1487
  • [38] Current Perspectives on Ophthalmic Manifestations of Childhood Rheumatic Diseases
    Neal V. Palejwala
    Steven Yeh
    Sheila T. Angeles-Han
    Current Rheumatology Reports, 2013, 15
  • [39] Current Perspectives on Ophthalmic Manifestations of Childhood Rheumatic Diseases
    Palejwala, Neal V.
    Yeh, Steven
    Angeles-Han, Sheila T.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (07)
  • [40] Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab na⟨ve, recurrent glioblastoma
    Reardon, David A.
    Desjardins, Annick
    Peters, Katherine B.
    Gururangan, Sridharan
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Bulusu, Anuradha
    Threatt, Stevie
    Friedman, Allan H.
    Vredenburgh, James J.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) : 155 - 164
12345